Winter G, Hart RA, Charlesworth RPG, Sharpley CF
Often, yes, when your treatment plan includes it
Wegovy is a glucagon-like peptide-1 receptor agonist (also called a GLP-1 medication) that has been approved by the Food and Drug Administration (FDA) for the following indications: to help with weight loss and long-term weight management in certain adults and children who are overweight or have obesity to reduce the risk of major adverse cardiovascular (CV) events (heart attack, stroke, or CV death) in adults with established cardiovascular disease who are overweight or have obesity to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced liver fibrosis Wegovy is typically prescribed as part of a treatment plan that includes a healthy, reduced-calorie diet and regular exercise

One honest sentence up front, because it governs everything that follows: Ipamorelin is not an FDA-approved drug , its human clinical record is limited, and much of what is presented as an expected outcome comes from preclinical work and early characterization studies rather than large, long-term human trials
Here's how much you will pay